Skip to content
10-Q

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001562884-21-000040

← back to feed
Filed
Sep 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity Q1 2020 · Mar 31, 2020 −$26.98K
Stockholders Equity Q1 2020 · Dec 31, 2019 −$22.58K
Current Liabilities Q1 2020 · Mar 31, 2020 $26.98K
Current Liabilities Q1 2020 · Dec 31, 2019 $22.58K
Total Assets Q1 2020 · Mar 31, 2020 $0
Total Assets Q1 2020 · Dec 31, 2019 $0
Operating Cash Flow Q1 2020 · Mar 31, 2019 $0
Sga Expense Q1 2020 · Mar 31, 2019 $6.26K
Net Income Q1 2020 · Mar 31, 2019 −$6.26K
Operating Income Q1 2020 · Mar 31, 2019 −$6.26K
Revenue Q1 2020 · Mar 31, 2019 $0